Drug Type Small molecule drug |
Synonyms UCT 01 097, UCT 01-097 |
Target |
Mechanism ERK1 inhibitors(Extracellular-signal-regulated kinase1 inhibitors), ERK2 inhibitors(Extracellular-signal-regulated kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization 1200 Pharma LLCStartup |
Active Organization |
Inactive Organization 1200 Pharma LLCStartup |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | US | 1200 Pharma LLCStartup | 03 Mar 2021 |
Neoplasms | Preclinical | US | 04 Apr 2023 |